Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue SUPPL. 1, 2003, Pages

  Swerdlow, A J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

AIDS; Epidemiology; Epstein Barr virus; Hodgkin's disease; Non Hodgkin's lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; HODGKIN DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; NONHODGKIN LYMPHOMA; REVIEW; RISK FACTOR; VIRUS INFECTION;

EID: 0038805260     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1154-9     Document Type: Review

References (100)

1. Swerdlow A, dos Santos Silva I, Doll R. Cancer incidence and mortality in England and Wales: trends and risk factors. Oxford University Press: Oxford, 2001.
2. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Trends in mortality from Hodgkin's disease in western and eastern Europe. Br J Cancer 2002; 87:291-293.
3. Sant M, Capocaccia R, Coleman MP, Berrino F, Gatta G, Micheli A, Verdecchia A, Faivre J, Hakulinen T, Coebergh JWW, Martinez-Garcia C, Forman D, Zappone A, and the EUROCARE Working Group. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37:1659-1667.
4. SEER. Surveillance, Epidemiology, and End Results Program Public-Use Data (1973-1999). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2002, based on the November 2001 submission. http://seer.cancer.gov/publicdata/. 2002.
5. Pastore G, Magnani C, Verdecchia A, Pession A, Viscomi S, Coebergh JWW, and the EUROCARE Working Group. Survival of childhood lymphomas in Europe, 1978-1992: a report from the EUROCARE study. Eur J Cancer 2001; 37:703-710.
6. Banks PM. Changes in diagnosis of non-Hodgkin's lymphomas over time. Cancer Res 1992; 52:5453s-5455s.
7. Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer 1990; 66:2196-2204.
8. Martinsson U, Glimelius B, Sundströn C. Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol 1992; 31:275-282.
9. Hasle H, Mellemgaard A. Hodgkin's disease diagnosed post mortem: a population based study. Br J Cancer 1993; 67:185-189.
10. Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M. Incidence of Hodgkin's disease in Nordic countries. Lancet 2001; 358:297-298.
11. Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Prev 1992; 1:261-268.
12. Stiller CA. What causes Hodgkin's disease in children? Eur J Cancer 1998; 34:523-528.
13. Correa P, O'Conor GT. Epidemiologic patterns of Hodgkin's disease. Int J Cancer 1971; 8:192-201.
14. MacFarlane GJ, Evstifeeva T, Boyle P, Grufferman S. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 1995; 61:165-169.
15. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents. Volume VII. IARC Scientific Publication No. 143. Lyon: IARC, 1997.
16. Parkin DM, Kramárová E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA, eds. International incidence of childhood cancer. Volume II, IARC Scientific Publication No. 144. Lyon: IARC, 1998.
17. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966; 26:1189-1200.
18. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease in the young. Int J Cancer 1977; 19:595-604.
19. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981; 304:135-140.
20. Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 1997; 72:977-981.
21. Mueller NE, Grufferman S. The epidemiology of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's disease. Philadelphia: Lippincott Williams & Wilkins; 1999:61-77.
22. Glaser SL, Clarke CA, Nugent RA, Steams CB, Dorfman RF. Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer 2002; 98:110-117.
23. Glaser SL, Clarke CA, Steams CB, Dorfman RF. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymphoma 2001; 42:997-1004.
24. Hjalgrim H, Rostgaard K, Askling J, Madsen M, Storm HH, Rabkin CS, Melbye M. Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis. J Natl Cancer Inst 2002; 94:678-681.
25. Hjalgrim H, Askling J, Sorensen P, Madsen M, Rosdahl N, Storm HH, Hamilton-Dutoit S, Eriksen LS, Frisch M, Ekbom A, Melbye M. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 2000; 92:1522-1528.
26. Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 1998; 7:1117-1121.
27. Alexander FE, Jarrett RF, Lawrence D, Armstrong AA, Freeland J, Gokhale DA, Kane E, Taylor GM, Wright DH, Cartwright RA. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer 2000; 82:1117-1121.
28. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JKC, Claviez A. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70:375-382.
29. Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol 2002; 13:23-29.
30. Flavell K, Constandinou C, Lowe D, Scott K, Newey C, Evans D, Dutton A, Simmons S, Smith R, Crocker J, Young LS, Murray P. Effect of material deprivation on Epstein-Barr virus infection in Hodgkin's disease in the West Midlands. Br J Cancer 1999; 80:604-608.
31. Flavell KJ, Biddulph JP, Powell JE, Parkes SE, Redfern D, Weinreb M, Nelson P, Mann JR, Young LS, Murray PG. South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease. Br J Cancer 2001; 85:350-356.
32. Weinreb M, Day PJR, Niggli F, Powell JE, Raafat F, Hesseling PB, Schneider JW, Hartley PS, Tzortzatou-Stathopoulou F, Khalek ERA, Mangoud A, El-Safy UR, Madanat F, Al Sheyyab M, Mpofu C, Revesz T, Rafii R, Tiedemann K, Waters KD, Barrantes JC, Nyongo A, Riyat MS, Mann JR. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996; 74:27-31.
33. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27:390-401.
34. Frisch M, Biggar RJ, Engels EA, Goedert JJ, for the AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285:1736-1745.
35. Clarke CA, Glaser SL. Epidemiologic trends in HIV-associated lymphomas. Curr Opin Oncol 2001; 13:354-359.
36. Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992; S52:5465s-5467s.
37. Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socié G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol 1999; 17:3122-3127.
38. Hoover R. Effects of drugs - immunosuppression. In: Hiatt HH, Watson JD, Winsten JA, eds. Origins of human cancer.1 Book A. Incidence of cancer in humans. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1977:369-379.
39. Kinlen LJ, Sheil AGR, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. BMJ 1979; 2:1461-1466.
40. Sheil AGR, Disney APS, Mathew TG, Amiss N, Excell L. Malignancy following renal transplantation. Transplant Proc 1992; 24:1946-1947.
41. Hoshida Y, Tsukuma H, Yasunaga Y, Xu N, Fujita MQ, Satoh T, Ichikawa Y, Kurihara K, Imanishi M, Matsuno T, Aozasa K. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71:517-520.
42. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohmé I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frödin L, Glattre E, Halvorsen S, Holm NV, Jakobsen A, Jørgensen HE, Ladefoged J, Lindholm T, Lundgren G, Pukkala E. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60:183-189.
43. Glaser SL. Reproductive factors in Hodgkin's disease in women: a review. Am J Epidemiol 1994; 139:237-246.
44. Kravdal O, Hansen S. Hodgkin's disease: the protective effect of childbearing. Int J Cancer 1993; 55:909-914.
45. McCunney RJ. Hodgkin's disease, work, and the environment. A review. J Occup Environ Med 1999; 41:36-46.
46. Grufferman S, Davis MK, Ambinder RF, Shugart YY, Gilchrist GS, Brecher ML. A protective effect of breastfeeding on risk of Hodgkin's disease in children. Paediatr Perinat Epidemiol 1998; 12:A13.
47. Grufferman S, Cole P, Smith PG, Lukes RJ. Hodgkin's disease in siblings. N Engl J Med 1977; 296:248-250.
48. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, Taylor CR, Hamilton AS, Deapen DM, Rappaport EB. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 332:413-418.
49. Easton D, Peto J. The contribution of inherited predisposition to cancer incidence. Cancer Surv 1990; 9:395-416.
50. Grufferman S, Barton JW III, Eby NL. Increased sex concordance of sibling pairs with Behçet's disease, Hodgkin's disease, multiple sclerosis, and sarcoidosis. Am J Epidemiol 1987; 126:365-369.
51. Swerdlow AJ, De Stavola BL, Maconochie N, Siskind V. A population-based study of cancer risk in twins: relationships to birth order and sexes of the twin pair. Int J Cancer 1996; 67:472-478.
52. Hartge P, Devesa SS, Fraumeni JF Jr. Hodgkin's and non-Hodgkin's lymphomas. In: Doll R, Fraumeni JF Jr, Muir CS, eds. Trends in cancer incidence and mortality, 19-20. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1994:423-453.
53. Gatter KC, Alcock C, Heryet A, Mason DY. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet 1985; 1:1302-1305.
54. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002; 94:2015-2023.
55. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:1204-1210.
56. Olsen JH, Hahnemann JM, Børresen-Dale A-L, BrøndumNielsen K, Hammarström L, Kleinerman R, Kääräinen H, Lönnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD Jr, Tucker M. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 2001; 93:121-127.
57. Kinlen LJ, Webster ADB, Bird AG, Haile R, Peto J, Soothill JF, Thompson RA. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985; 1:263-266.
58. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987; 7:294-299.
59. Opelz G, Henderson R, for the Collaborative Transplant Study. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342:1514-1516.
60. Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94:2208-2216.
61. Swerdlow AJ, Higgins CD, Hunt BJ, Thomas JA, Burke MM, Crawford DH, Yacoub MH. Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus. Transplantation 2000; 69:897-904.
62. Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 2000; 14:133-140.
63. Grulich AE. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 1999; 21 Suppl 1:S27-S30.
64. Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area. Allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:211-222.
65. Kinlen LJ, Eastwood JB, Kerr DNS, Moorhead JF, Oliver DO, Robinson BHB, de Wardener HE, Wing AJ. Cancer in patients receiving dialysis. BMJ 1980; 280:1401-1403.
66. Kendrick MA, Comstock GW. BCG vaccination and the subsequent development of cancer in humans. J Natl Cancer Inst 1981; 66:431-437.
67. Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287:1413-1419.
68. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989; 30:333-338.
69. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Guidetti CS, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabró A, Certo M, for the Club del Tenne Study Group. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358:356-361.
70. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, Lutz CT. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997; 89:314-318.
71. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A. Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997; 241:471-475.
72. Askling J, Ekbom A. Risk of non-Hodgkin's lymphoma following tuberculosis. Br J Cancer 2001; 84:113-115.
73. Zhang SM, Calle EE, Petrelli JM, Jacobs EJ, Thun MJ. Vitamin supplement use and fatal non-Hodgkin's lymphoma among US men and women. Am J Epidemiol 2001; 153:1064-1070.
74. Chiu BCH, Weisenburger DD, Cantor KP, Zahm SH, Holmes F, Burmeister LF, Blair A. Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of nonHodgkin's lymphoma in men. Ann Epidemiol 2002; 12:309-315.
75. Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, Zahm SH, Needham LL, Pearson GR, Hoover RN, Comstock GW, Strickland PT. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350:240-244.
76. Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 1991; 49:387-393.
77. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 1990; 137:13-18.
78. Cleghom FR, Manns A, Falk R, Hartge P, Hanchard B, Jack N, Williams E, Jaffe E, White F, Bartholomew C, Blattner W. Effect of human T-lymphotropic virus type I infection on nonHodgkin's lymphoma incidence. J Natl Cancer Inst 1995; 87:1009-1014.
79. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353:1951-1958.
80. Wotherspoon AC. Helicobacter pylori infection and gastric lymphoma. Br Med Bull 1998; 54:79-85.
81. Vineis P, Crosignani P, Sacerdote C, Fontana A, Masala G, Miligi L, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Viganò C, Vindigni C, Costantini AS. Hematopoietic cancer and peptic ulcer: a multicenter case-control study. Carcinogenesis 1999; 20:1459-1463.
82. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267-1271.
83. Swerdlow AJ, Barber JA, Vaughan Hudson G, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18:498-509.
84. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B, MacLennan KA. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 1993; 68:1006-1011.
85. Kaldor JM, Day NE, Band P, Choi NW, Clarke EA, Coleman MP, Hakama M, Koch M, Langmark F, Neal FE, Pettersson F, Pompe-Kirn V, Prior P, Storm HH. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 1987; 39:571-585.
86. National Radiological Protection Board. ELF electromagnetic fields and the risk of cancer. Report of an Advisory Group on Non-Ionising Radiation. Documents of the NRPB, vol 12, no.1. Chilton: NRPB, 2001.
87. National Radiological Protection Board. Health effects from ultraviolet radiation. Report of an Advisory Group on Non-Ionising Radiation. Documents of the NRPB, vol 13, no. 1. Chilton: NRPB, 2002.
88. Peach HG, Barnett NE. Critical review of epidemiological studies of the association between smoking and non-Hodgkin's lymphoma. Hematol Oncol 2001; 19:67-80.
89. Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Berg BJ van den. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99:4240-4242.
90. Chow EJ, Holly EA. Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study. Am J Epidemiol 2002; 155:725-731.
91. Nelson RA, Levine AM, Bernstein L. Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women. J Clin Oncol 2001; 19:1381-1387.
92. Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999; 150:375-389.
93. McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman JA, Robson D, Skinnider LF, Choi NW. NonHodgkin's lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 2001; 10:1155-1163.
94. Zheng T, Zahm SH, Cantor KP, Weisenburger DD, Zhang Y, Blair A. Agricultural exposure to carbamate pesticides and risk of non-Hodgkin lymphoma. J Occup Environ Med 2001; 43:641-649.
95. Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE, Rothman N, Cantor KP, Blair A. Agricultural risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma. Epidemiology 2001; 12:701-709.
96. Meinert R, Schüz J, Kaletsch U, Kaatsch P, Michaelis J. Leukemia and non-Hodgkin's lymphoma in childhood and exposure to pesticides: results of a register-based case-control study in Germany. Am J Epidemiol 2000; 151:639-646.
97. Olshan AF, Daniels JL. Pesticides and childhood cancer. Am J Epidemiol 2000; 151:647-649.
98. Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel S, Robison LL. Pesticide exposures in children with non-Hodgkin lymphoma. Cancer 2000; 89:2315-2321.
99. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in firstdegree relatives of cancer probands. J Natl Cancer Inst 1994; 86:1600-1608.
100. Zhu K, Levine RS, Gu Y, Brann EA, Hall I, Caplan LS, Baum MK. Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 1998; 9:77-82.